Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Axsome Therapeutics, Inc.(AXSM) | 2,360,077 | 2,360,077 | 0 | $189.99M | $212.10M | 17.20% | +$22.11M |
| Nuvalent Inc | 1,924,626 | 1,687,064 | -237,562 | $146.00M | $172.59M | 13.99% | +$26.58M |
| Apogee Therapeutics Inc | 2,048,647 | 2,048,647 | 0 | $80.61M | $120.34M | 9.76% | +$39.72M |
| Spyre Therapeutics, Inc.(SYRE) | 4,018,101 | 4,018,101 | 0 | $94.47M | $118.17M | 9.58% | +$23.71M |
| Enliven Therapeutics Inc | 3,202,798 | 3,202,798 | 0 | $74.85M | $81.80M | 6.63% | +$6.95M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 3,204,841 | 3,204,841 | 0 | $59.83M | $80.09M | 6.49% | +$20.25M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 3,211,922 | +3,211,922 | $0 | $78.72M | 6.38% | +$78.72M |
| Viridian Therapeutics, Inc.(VRDN) | 1,845,813 | 3,445,813 | +1,600,000 | $24.01M | $78.39M | 6.36% | +$54.38M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,762,837 | 2,700,691 | -62,146 | $71.50M | $73.94M | 6.00% | +$2.44M |
| Cogent Biosciences, Inc.(COGT) | 6,225,641 | 6,225,641 | 0 | $52.48M | $67.24M | 5.45% | +$14.75M |
| Day One Biopharmaceuticals Inc COM | 0 | 3,103,448 | +3,103,448 | $0 | $43.23M | 3.51% | +$43.23M |
| Astria Therapeutics Inc | 3,554,129 | 3,554,129 | 0 | $32.34M | $39.13M | 3.17% | +$6.79M |
| Bicara Therapeutics Inc | 0 | 1,284,169 | +1,284,169 | $0 | $32.71M | 2.65% | +$32.71M |
| Zenas BioPharma, Inc.(ZBIO) | 0 | 1,892,806 | +1,892,806 | $0 | $32.03M | 2.60% | +$32.03M |
| Bicycle Therapeutics PlcADS | 1,069,199 | 123,538 | -945,661 | $21.64M | $2.80M | 0.23% | -$18.84M |
| Protagonist Therapeutics Inc | 931,890 | 0 | -931,890 | $32.29M | $0 | — | -$32.29M |
| Terns Pharmaceuticals Inc | 748,996 | 0 | -748,996 | $5.10M | $0 | — | -$5.10M |